3-(3-fluoro-4-methoxyphenyl)propionyl chloride | 83802-70-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 3-(3-fluoro-4-methoxyphenyl)propionyl chloride
• 英文别名: 3-(3-Fluoro-4-methoxyphenyl)propanoyl chloride
• CAS: 83802-70-4
• 化学式: C₁₀H₁₀ClFO₂
• 分子量: 216.64
• InChiKey: PZCFZJYDMVVELK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-(3-fluoro-4-methoxyphenyl)propionyl chloride 在 三氯化铝 作用下， 以 二硫化碳 为溶剂， 反应 1.0h， 以96%的产率得到5-氟-2,3-二氢-6-甲氧基-1H-茚-1-酮
  参考文献：
  名称：

  Synthesis and antianxiety activity of (.omega.-piperazinylalkoxy)indan derivatives

  摘要：

  A series of (omega-piperazinylalkoxy)indan derivatives has been synthesized and screened for potential antianxiety activities. The effect of structural modification of these molecules on activities has been systemically examined. Antianxiety activity was displayed by 5-[3-(4-phenyl-1-piperazinyl)propoxy]indan (2), 5-[3-[4-(4-fluorophenyl)-1-piperazinyl]-propoxy]indan (8), 6-fluoro-5-[3-(4-phenyl-1-piperazinyl)propoxy]indan (33), and 6-methyl-5-[3-(4-phenyl-1-piperazinyl)propoxy]indan (42), as determined in antifighting and anti-morphine tests. These derivatives in antianxiety tests were equipotent or more potent than chlordiazepoxide with less muscle-relaxant effect. They also showed weak neuroleptic-like action.

  DOI：

  10.1021/jm00356a024
• 作为产物：
  描述：

  3-氟-4-甲氧基苯甲醛 在 吡啶 、 氯化亚砜 、 palladium 10% on activated carbon 、 氢气 作用下， 以 四氢呋喃 、 二氯甲烷 、 甲苯 为溶剂， 生成 3-(3-fluoro-4-methoxyphenyl)propionyl chloride
  参考文献：
  名称：

  Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate

  摘要：

  DOI：

  10.1021/acs.jmedchem.0c01863

文献信息

• Synthesis and antianxiety activity of (.omega.-piperazinylalkoxy)indan derivatives
  作者：Ryoji Kikumoto、Akihiro Tobe、Harukazu Fukami、Mitsuo Egawa

  DOI：10.1021/jm00356a024

  日期：1983.2

  A series of (omega-piperazinylalkoxy)indan derivatives has been synthesized and screened for potential antianxiety activities. The effect of structural modification of these molecules on activities has been systemically examined. Antianxiety activity was displayed by 5-[3-(4-phenyl-1-piperazinyl)propoxy]indan (2), 5-[3-[4-(4-fluorophenyl)-1-piperazinyl]-propoxy]indan (8), 6-fluoro-5-[3-(4-phenyl-1-piperazinyl)propoxy]indan (33), and 6-methyl-5-[3-(4-phenyl-1-piperazinyl)propoxy]indan (42), as determined in antifighting and anti-morphine tests. These derivatives in antianxiety tests were equipotent or more potent than chlordiazepoxide with less muscle-relaxant effect. They also showed weak neuroleptic-like action.
• KIKUMOTO, RYOJI;TOBE, AKIHIRO;FUKAMI, HARUKAZU;EGAWA, MITSUO, J. MED. CHEM., 1983, 26, N 2, 246-250
  作者：KIKUMOTO, RYOJI、TOBE, AKIHIRO、FUKAMI, HARUKAZU、EGAWA, MITSUO

  DOI：——

  日期：——
• Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate
  作者：Yu Zhou、Yan Fu、Wanchao Yin、Jian Li、Wei Wang、Fang Bai、Shengtao Xu、Qi Gong、Tao Peng、Yu Hong、Dong Zhang、Dan Zhang、Qiufeng Liu、Yechun Xu、H. Eric Xu、Haiyan Zhang、Hualiang Jiang、Hong Liu

  DOI：10.1021/acs.jmedchem.0c01863

  日期：2021.2.25